Introduction: Degenerative mitral valve disease (DMR) is a common valvular disorder, and flail leaflet due to ruptured chordae represents an extreme variation of this pathology. Ruptured chordae can present as acute heart failure which requires urgent intervention. Mitral valve surgery is the preferred mode of intervention; however, some patients represent as a significant surgical risk and are often deemed to be inoperable. We aim to characterize patients with ruptured chordae undergoing urgent transcatheter edge-to-edge repair (TEER), and to analyze their clinical and echocardiographic outcomes. Methods: At a referral center for several hospitals across Israel, we screened all patients who underwent TEER. We included patients with DMR with flail leaflet due to ruptured chordae, and categorized them into elective and critically ill groups. We evaluated the echocardiographic, hemodynamic and clinical outcomes of these patients. Results: The cohort included 49 patients with DMR due to ruptured chordae and flail leaflet, who underwent TEER. Seventeen patients (35%) underwent urgent intervention and 32 patients (65%) underwent an elective procedure. In the urgent group, the average age of the patient was 80.3, with 41.8% being female. Fourteen (82%) received noninvasive ventilation, while three patients (18%) required invasive mechanical ventilation. One patient died due to tamponade, while the other 16 patients all had successful reduction of 2 in the MR grade. Left atrial V wave decreased from 41.6 mmHg to 17.9 mmHg (p<0.001), and pulmonic vein flow pattern changed from reversal (68.8%) to a systolic dominant flow in all patients (p=0.001). After the procedure, 78.5% of patients were in New York Heart Association (NYHA) class I or II (p<0.001). There was no significant difference in the overall mortality between the urgent and elective groups, with similar survival rates of 6 months for each group. Conclusion: TEER can be safe and feasible with favorable hemodynamic, echocardiographic and clinical outcomes in patients undergoing urgent intervention for flail mitral valve disease.

The authors have declared no competing interest.

i recived no funding for witing this article

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Shaare Zedek Medical Center committe for human studies (0261-18-SZMC)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

all data avilable in this manuscript is original